Image

Effects of Autogenic Inhibition and Reciprocal Inhibition in Amateur Football Players With Shin Splints.

Effects of Autogenic Inhibition and Reciprocal Inhibition in Amateur Football Players With Shin Splints.

Recruiting
18-30 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled trial aims to compare the effectiveness of Autogenic Inhibition and Reciprocal Inhibition in treating shin splints among amateur footballers aged 18-30 from SA Gardens Football Club, Lahore. Participants will be recruited through non-probability convenient sampling and randomly assigned into two groups using random number sampling. A single-blind approach will be employed, with one group receiving Autogenic Inhibition treatment and the other receiving Reciprocal Inhibition treatment over a period of four weeks, with three sessions per week. The study will measure outcomes including pain alleviation, improvement in range of motion (ROM), enhanced function, and improved sports performance. This research seeks to provide insights into the benefits of muscle energy techniques for athletes with shin splints, contributing valuable knowledge to sports medicine and rehabilitation practices.

Description

Recent literature provides substantial evidence supporting the efficacy of muscle energy techniques (METs), including Autogenic Inhibition, for various musculoskeletal conditions across different populations. Robert F. et al. (2023) conducted a quasi-experimental study using a pre- and post-test design to compare Kalternborn grade III mobilization and METs in 30 patients, finding significant improvements in pain and neck function. Siddiqui M. et al. (2022) demonstrated in a randomized control trial that Autogenic Inhibition was more effective than Reciprocal Inhibition in improving pain, range of motion, and functional disability in patients with mechanical neck pain. Similarly, Osama M. et al. (2022) found Autogenic Inhibition to be the most effective among static stretching, AI-MET, and RI-MET for enhancing isometric muscle strength in neck pain patients. Majeed A. et al. (2021) showed that Autogenic Inhibition had better outcomes than static stretching for hamstring flexibility. Khaled H. Yousef et al. revealed that adding METs to conventional therapy significantly improved pain, impairment, and hip range of motion in patients with chronic discogenic sciatica. A systemic review by Thomas E. et al. (2019) confirmed METs' effectiveness in reducing chronic and acute pain and improving range of motion. Despite these positive findings, there is limited research on METs for sports-related conditions like shin splints. This study aims to fill this gap by examining the specific benefits and drawbacks of a structured MET program for shin splints in a sports environment, providing valuable insights for athletes in managing and preventing overuse and bone stress injuries efficiently.

Eligibility

Inclusion Criteria:

  1. Both genders.
  2. Age 18-30 years.
  3. Those who are actively taking part in sports from last 1 year.
  4. Subjects who have NPRS scores from moderate pain (NPRS 4-6) to severe pain (NPRS 7- 10).
  5. Subjects diagnosed with category 2 Shin splints through Shin splint scoring system (Male 2- 14, Female 6-16) and category 3 (Male 14-29, Female 17-29).

Exclusion Criteria:

  1. History of Central or peripheral vascular disease.
  2. History of lower limb fracture / Trauma (Any side) in last 6 months.
  3. History of lower limb Surgery (Any side) in last 6 months.
  4. History of any malignancy.
  5. Leg length discrepancy.
  6. Biomechanical imbalances.

Study details
    Shin Splint

NCT06501430

Riphah International University

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.